By Faith Patenaude, Investor Research Analyst, LSN
300 life science investors focused on clinical and preclinical companies are expected to attend RESI Europe. 100 are already confirmed! RESI Europe will be held in Barcelona in-person on June 17 and virtual June 18-19. Your members can meet more investors at RESI Europe than at any other partnering event in Europe. RESI Europe features a shark-tank like investor pitch challenge as well as 1-to-1 partnering. We invite tech hubs and their members to take advantage of special rates:
- Super Early Bird Rate on RESI Registration for tech hub members who have raised less than $2 million USD.
- Complimentary Ticket for a Second Attendee when purchasing a RESI Innovator’s Pitch Challenge (IPC) Package.
- 50% Off RESI Sponsorship, enhancing your visibility and networking opportunities.
- Discounted Subscription to the LSN Investor Database, providing access to over 10,000 investor contacts.
Contact Erika Wu E.WU@LifeScienceNation.com to discuss your eligibility and to access the appropriate discount codes.
RESI Europe stands as an exceptional platform for early-stage life science companies, providing unparalleled opportunities to engage and connect with a diverse array of European and global investors. The LSN investor research team has been diligently working to invite investors, including CVC, angel groups, family offices, venture capital funds, big pharma, and more. Each investor has undergone thorough vetting to ensure alignment with company profiles, guaranteeing a distinctive edge over other conferences and fostering high-caliber attendance. RESI’s partnering platform welcomes the opportunity for you to connect with investors with aligned interests and of best fit. RESI offers an outstanding chance for early-stage startups, service providers, and investors to cultivate meaningful connections and broaden their network within the life science sector.
Save up to €300 with our early bird rate – ending tomorrow, Friday May 17th. Sign up now and join the featured investors below.
Next Phase Newsletter 
Leave a comment